CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies-Reference-Cited by-同舟云学术

CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies

Published:2018-02-08 Issue:6 Volume:131 Page:611-620
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Green Damian J.¹²^ORCID,O’Steen Shyril¹^ORCID,Lin Yukang¹^ORCID,Comstock Melissa L.¹,Kenoyer Aimee L.¹,Hamlin Donald K.³,Wilbur D. Scott³,Fisher Darrell R.⁴^ORCID,Nartea Margaret¹,Hylarides Mark D.¹^ORCID,Gopal Ajay K.¹²,Gooley Theodore A.¹^ORCID,Orozco Johnnie J.¹²^ORCID,Till Brian G.¹²^ORCID,Orcutt Kelly D.⁵⁶,Wittrup K. Dane⁵⁶,Press Oliver W.¹²^ORCID

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

2. Department of Medicine and

3. Department of Radiation Oncology, University of Washington, Seattle, WA;

4. Versant Medical Physics, Richland, WA; and

5. Department of Chemical Engineering and

6. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA

Abstract

Key Points A novel bispecific antibody against CD38 eradicates MM and NHL tumors in murine models. CD38-bispecific antibody pretargeting addresses limitations associated with radioimmunotherapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/6/611/1466540/blood807610.pdf

Reference57 articles.

1. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma;Lin;Am J Clin Pathol,2004

2. Human CD38: a (r)evolutionary story of enzymes and receptors;Deaglio;Leuk Res,2001

3. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors;de Weers;J Immunol,2011

4. Targeting CD38 with daratumumab monotherapy in multiple myeloma;Lokhorst;N Engl J Med,2015

5. Oncogenomics to target myeloma in the bone marrow microenvironment;Anderson;Clin Cancer Res,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

2. Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma;Exploration of Targeted Anti-tumor Therapy;2024-02-28

3. Microarray-Based CD38 Peptide Probe Screening for Multiple Myeloma Imaging;Molecular Pharmaceutics;2023-12-14

4. [177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-08

5. Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review;Journal of Controlled Release;2023-07